Your browser doesn't support javascript.
loading
The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy.
John, Peter; Pulanco, Marc C; Galbo, Phillip M; Wei, Yao; Ohaegbulam, Kim C; Zheng, Deyou; Zang, Xingxing.
Afiliação
  • John P; Department of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, NY, United States.
  • Pulanco MC; Department of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, NY, United States.
  • Galbo PM; Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Wei Y; Department of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, NY, United States.
  • Ohaegbulam KC; Department of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, NY, United States.
  • Zheng D; Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Zang X; Departments of Neurology and Neuroscience, Albert Einstein College of Medicine, Bronx, NY, United States.
Nat Commun ; 13(1): 2506, 2022 05 06.
Article em En | MEDLINE | ID: mdl-35523809

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos B7 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos B7 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article